MARKET WIREReuters • 3h ago
Russia's FSB says minor detained over park attack threat after US tip-off - ReutersRussia's FSB says minor detained over park attack threat after US tip-off Reuters
Why USNA Stock slipped -1.91% Today — RQD Quant Desk Flash
$14.34 -1.91% NYSE • Live Quote vs Prior Daily Close (Synced Snapshot)
EXT / AFTER-HRS: $14.26
USANA Health Sciences Inc. (USNA) carries a Roarable Rating of C- (Hold) with 61/100 RQD Confidence. The composite score sits in the neutral Hold band (59–69), meaning current holders don’t need to panic-sell while prospective buyers can wait for a move into the 70+ Buy zone.
ROARABLE C- • HOLD / WATCH
Cap $265.0M
⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER
Click Any Pre-Computed AI Quant Specialist Briefing on USNA Below — or Connect Your Own ChatGPT / Claude
🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief)
Is USNA stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
▼
As of 2026-11-01, USANA Health Sciences Inc. (NYSE: USNA) is rated C- (Hold / HOLD) by Roarable's 5-pillar RQD engine with a composite confidence score of 61/100 at a spot price of $14.34 (-1.91% 1D, market cap $265.0M). Pillar breakdown: Fundamental Cash Engine 12/20, Institutional 13F & Options Flow 9/20, Executive Insider Alignment 14/20, FRED Macro Regime Fit 13/20, and SEC Balance-Sheet Forensics 13/20. Across 1016 tracked Health Care issuers, USNA ranks #193 in composite RQD confidence.
✓ Pre-computed one-to-many AI Quant brief
🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief)
How does USNA compare to ACB and CGC in the Health Care sector?
▼
Within the Health Care sector (Medicinal Chemicals and Botanical Products), USNA carries a Roarable C- (61/100 RQD), trailing P/E of 24.6x, gross margin of 78.3%, and ROIC of 7.9%. By comparison, ACB (Aurora Cannabis Inc.) holds a D+ grade (58/100 RQD, P/E N/A, ROIC —, cap $252.8M) and CGC (Canopy Growth Corporation) posts a D grade (51/100 RQD, P/E N/A, ROIC —, cap $285.6M). Among the 5-stock peer group, USNA leads on earnings multiple (24.6x) while USNA leads on capital efficiency (7.9% ROIC).
✓ Pre-computed one-to-many AI Quant brief
🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief)
What are the biggest fundamental strengths and SEC risk factors for USNA?
▼
Per USNA's SEC EDGAR XBRL 10-K filing (FY2025, filed 2026-01-03, CIK 0000896264), USANA Health Sciences Inc. generated $925.3M in revenue (+8.3% YoY), $10.8M in net income, and $8.5M in free cash flow against $742.9M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Health Care with deep daily trading liquidity.. Primary risk factors monitored: Broader market pullbacks can still drag down strong stocks in the short run.. Institutional options positioning shows a 50% call / 50% put premium split.
✓ Pre-computed one-to-many AI Quant brief
🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).
INTERACTIVE SCENARIO DECK:
EXT / AFTER-HRS: $14.26 (-0.53%)🧬 Cannibal Buyback (-1.52% YoY Shares)⚙️ Cash Engine: 12/20 (C-) • 0.9% FCF Margin
Verify 90D Bucket Audit →📊 Historical Track Record: Scores of 61/100 (C-) historically posted market-perform odds over rolling 90-day windows (+0.5% avg 90D alpha vs SPY • 53.9% hit rate — wait for RQD ≥ 70 breakout).
Audit Bucket Track Record →RQD QUANT TACHOMETERHOLD / WATCH • C-
JEV AI Jury Split (Battleground)
Cash
SEC
Whale
Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer
5-PILLAR SNOWFLAKE RADARRw D+ · Rk C+
Each axis scored 0–20
12M PRICE TARGET CONE+1.3% Base Target
WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for USNA)Realized 20D OHLCV Swing Band: ±8.9%
Deterministic 5-Pillar Attribution (61/100 Composite)
🔍 WHY USNA SCORES 61/100 (C-) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag
▲ #1 Bullish Driver: SEC 10-K Forensic Risk+14/20 pts (23% of score)
Altman Z-Score 3.56 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 7/9
▲ #2 Bullish Driver: Macro Regime Fit+13/20 pts (21% of score)
FRED Regime × Technicals: 16% of 52W Range • RSI-14 at 45.3 (NEUTRAL RANGE)
▼ #1 Drag / Risk Factor: Whale & Options Positioning9/20 pts (-11 pt drag)
Put hedging (50% put share) caps near-term gamma upside (-11 pts vs max)
📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current
Q1 (-3Q)Grade B-$14.66+6% Next Q
69
Q2 (-2Q)Grade B-$15.54-10.2% Next Q
66
Q3 (-1Q)Grade C+$13.96+2.7% Next Q
64
CurrentGrade C-$14.34+0.5% Hist 90D α
61
Trajectory: B- (69) → C- (61)Full Audit →
⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)GIDEON ASHMERE // FORENSIC SHORT & KILL-SWITCH DOSSIER
⚔️ Adversarial Opposing Case: Why the USNA Bull Thesis Could Fail
Even with a 61/100 (C-) score, USNA faces multiple-compression risk if 24.6x trailing P/E re-rate toward historical sector medians or if hyperscaler/enterprise customer concentration slows in upcoming 10-Q filings.
⚠️ Forensic Kill-Switch #1
Broader market pullbacks can still drag down strong stocks in the short run.
⚠️ Forensic Kill-Switch #2
Dilution & Margin Drag: Cannibal Buyback (-1.52% YoY Shares) — any gross margin slip below 75.8% triggers an automatic RQD downgrade.
⚠️ Forensic Kill-Switch #3
Technical & Forensic Kill-Switch: A daily close below the 50D SMA ($14.55) or 200D SMA ($18.11) invalidates the momentum regime and cuts Target Base ($14.53) toward Bear Floor ($11.33).
🎲 LIVE PREDICTION MARKET ODDS TIED TO $USNA• $2.4M Crowd Pool • Kalshi / Polymarket Composite
Contract: “USNA Beats Next Quarter EPS Consensus (Jan 2, 2027) & Holds Above 200D SMA”
AUTOMATED RQD QUANT DESK MOVER BRIEFINGFull Market News Desk →
Why USNA Stock slipped -1.91% Today — RQD Quant Desk Flash
USANA Health Sciences Inc. (USNA) slipped -1.91% to $14.34, trading at 16% of its 52-week range ($12.57 – $23.59). Solid 78% profit margin (8% return on capital), mixed timing at 25x P/E—hold if owned, no rush to chase.
- ▸Technical Tape: Trading at 16% of its 52-week range ($12.57 – $23.59) with RSI-14 at 45.3 (NEUTRAL RANGE).
- ▸Volatility Profile: Historical 20-day realized swing band of ±8.9% around $14.34 (no active unusual options sweep snapshot on file).
- ▸Fundamental Anchor: Roarable C- (Hold) backed by 78.3% gross margin and $8.5M annual free cash flow.
Live USNA Headlines & Catalysts
MARKET WIREReuters • 3h ago
Oil slips more than 1% as talks continue on ending Iran war - ReutersOil slips more than 1% as talks continue on ending Iran war Reuters
MARKET WIREReuters • 5h ago
Nine people dead in Learjet crash in south Florida, officials say - ReutersNine people dead in Learjet crash in south Florida, officials say Reuters
MARKET WIREReuters • 7h ago
Iran's IRGC Navy says two tankers 'exploded' after hitting mines in Hormuz - ReutersIran's IRGC Navy says two tankers 'exploded' after hitting mines in Hormuz Reuters
MARKET WIRECNBC • 9h ago
Here are 3 big things we're watching in the stock market in the week aheadThe market could use a few victories in the days ahead, which will be filled with more earnings, an election, and jobs data.
MARKET WIRECNBC • 9h ago
Democratic Rep. Stevens endorses Rogers over El-Sayed in Michigan Senate electionHaley Stevens had lost the Democratic nomination for Senate in Michigan to Abdul El-Sayed earlier this year.
RISK WATCHReuters • 10h ago
Israeli strikes kill eight people in Gaza - medics say - ReutersIsraeli strikes kill eight people in Gaza - medics say Reuters
MARKET WIREReuters • 12h ago
Iran, Qatari mediators hold third day of talks to end US-Iran war - ReutersIran, Qatari mediators hold third day of talks to end US-Iran war Reuters
ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Quantitative Research Desk
Scheduled RQD Strong Buys & Whale Accumulation Briefing (USNA Tape Review)
- ✓Breakdown of the highest-scoring RQD Green-Light breakouts across our 5,200+ rated universe
- ✓Forensic Red-Light accounting & dilution traps to review on your watchlist
- ✓Includes downloadable .ics calendar invite & nightly RQD rating-change email alerts
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
USNA // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -24.72%🛡️ HOLDING TREND SUPPORT
2026-10-30O $14.27H $14.47L $14.15C $14.34VOL 141.0K
RES: $26.69SUP: $13.70SMA50: $14.55SMA200: $18.11
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK
USNA Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Share Count & Dilution Monitor (#25)
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
Reverse-DCF Expectations Hurdle (#30)
18.3%/yr Implied 5Y Growth
vs. +8.3% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
Ellis Vennor Setup Ledger (#33)
No active Ellis Vennor swing setup published on USNA today. View full Setup Ledger →
🦋 Documented & Second-Order Butterfly Connections
Open Graph →
No direct multi-tier Butterfly edges indexed yet for USNA. Explore sector supply chains on /butterfly.
AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for USNA today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK
📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (USNA)
Health Care Rank #193 of 1016
⚔️ ACB vs USNA Full Matrix →
1. Head-to-Head Health Care Peer Comparison (USNA vs. ACB, CGC, SNDL, GLAS)
Industry: Medicinal Chemicals and Botanical Products (24 Tracked Issuers)Across 1016 tracked Health Care securities in the Roarable RQD universe, USANA Health Sciences Inc. (USNA) ranks #193 by composite RQD confidence (61/100, grade C-) and #535 by equity capitalization ($265.0M). Within this direct 5-issuer industry benchmark cohort, USNA leads on earnings valuation at 24.6x trailing P/E, while USNA leads on capital efficiency and profitability with 7.9% ROIC and 78.3% gross margin. USNA currently leads its immediate peer cohort in composite quantitative strength at 61/100 (C-).
| Ticker / Company | Roarable Grade | RQD Score | Trailing P/E | Gross Margin | ROIC | 1D Change | Market Cap | Head-to-Head |
|---|---|---|---|---|---|---|---|---|
| USNA
ACTIVE
USANA Health Sciences Inc. | C- | 61/100 | 24.6x | 78.3% | 7.9% | -1.91% | $265.0M | Benchmark Subject |
| ACB Aurora Cannabis Inc. | D+ | 58/100 | — | — | — | 0.00% | $252.8M | /acb-vs-usna → |
| CGC Canopy Growth Corporation | D | 51/100 | — | — | — | +0.46% | $285.6M | /cgc-vs-usna → |
| SNDL SNDL Inc. | C- | 61/100 | — | — | — | +0.78% | $316.3M | /sndl-vs-usna → |
| GLAS Glass House Brands Inc. Subordinate Voting Shares | E | 25/100 | — | 42.3% | -9.2% | +1.33% | $200.6M | /glas-vs-usna → |
2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)
SEC EDGAR 10-K • FILED 2026-01-03 • CIK 0000896264In its most recent audited fiscal period (FY2025, filed 2026-01-03), USANA Health Sciences Inc. (USNA) reported GAAP revenue of $925.3M (+8.3% vs. FY2024 revenue of $854.5M , and +0.5% cumulative change since FY2023) , GAAP net income of $10.8M, operating cash flow of $22.3M, and free cash flow of $8.5M (-83.3% YoY). On the balance sheet, USNA closed FY2025 with $742.9M in total assets against $0 in total debt (Altman Z-Score: 3.56, Piotroski F-Score: 7/9).
| Fiscal Period | Filing Date | Revenue | Net Income | Operating Cash Flow | Free Cash Flow | Total Assets | Total Debt |
|---|---|---|---|---|---|---|---|
| FY2025 (FY) | 2026-01-03 | $925.3M | $10.8M | $22.3M | $8.5M | $742.9M | — |
| FY2024 (FY) | 2024-12-28 | $854.5M | $42.0M | $61.0M | $50.9M | $748.2M | — |
| FY2023 (FY) | 2023-12-30 | $921.0M | $63.8M | $70.6M | $70.6M | — | — |
3. USNA Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)
✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLEDIs USNA stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
As of 2026-11-01, USANA Health Sciences Inc. (NYSE: USNA) is rated C- (Hold / HOLD) by Roarable's 5-pillar RQD engine with a composite confidence score of 61/100 at a spot price of $14.34 (-1.91% 1D, market cap $265.0M). Pillar breakdown: Fundamental Cash Engine 12/20, Institutional 13F & Options Flow 9/20, Executive Insider Alignment 14/20, FRED Macro Regime Fit 13/20, and SEC Balance-Sheet Forensics 13/20. Across 1016 tracked Health Care issuers, USNA ranks #193 in composite RQD confidence.
How does USNA compare to ACB and CGC in the Health Care sector?
Within the Health Care sector (Medicinal Chemicals and Botanical Products), USNA carries a Roarable C- (61/100 RQD), trailing P/E of 24.6x, gross margin of 78.3%, and ROIC of 7.9%. By comparison, ACB (Aurora Cannabis Inc.) holds a D+ grade (58/100 RQD, P/E N/A, ROIC —, cap $252.8M) and CGC (Canopy Growth Corporation) posts a D grade (51/100 RQD, P/E N/A, ROIC —, cap $285.6M). Among the 5-stock peer group, USNA leads on earnings multiple (24.6x) while USNA leads on capital efficiency (7.9% ROIC).
What are the biggest fundamental strengths and SEC risk factors for USNA?
Per USNA's SEC EDGAR XBRL 10-K filing (FY2025, filed 2026-01-03, CIK 0000896264), USANA Health Sciences Inc. generated $925.3M in revenue (+8.3% YoY), $10.8M in net income, and $8.5M in free cash flow against $742.9M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Health Care with deep daily trading liquidity.. Primary risk factors monitored: Broader market pullbacks can still drag down strong stocks in the short run.. Institutional options positioning shows a 50% call / 50% put premium split.
Where is USNA trading relative to its 50-day, 200-day, and 52-week technical levels?
USNA last traded at $14.34 (-1.91% on volume of 129,592 shares), positioning the stock -1.44% below its 50-day simple moving average ($14.55) and -20.82% below its 200-day simple moving average ($18.11). Across its 52-week range of $12.57 to $23.59, USNA sits at the 16.1% percentile with a 14-day RSI of 45.3 (NEUTRAL RANGE) and an implied next-earnings move of ±8.9% ($13.06 to $15.62).
USNA Investor FAQ & Complete 8-Part Research Index
100% OPEN ACCESS • SEC EDGAR × CBOE × FREDWhy is USNA stock moving today?
Why USNA Stock slipped -1.91% Today — RQD Quant Desk Flash. Solid 78% profit margin (8% return on capital), mixed timing at 25x P/E—hold if owned, no rush to chase.